![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home : About Us : Contact Us : Search : Site Map | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Post Expsoure Prophylaxis - Lab MonitoringNote: For management of specific exposures please see the PEP sections for “Occupational” and “Non-occupational” exposures in the Guideline section. For more details about the PEP protocol, please see the “PEP protocol” in the protocol section. I. Occupational Exposuresa) Non-HMC Employee Occupational Exposures:
* If source is known to be HBV or HCV negative, follow-up HBV and/or HCV serologies need not be drawn. b) HMC-Employee Occupational Exposures**:
** All HMC employees should receive the identical lab monitoring as non-HMC employees, but the lab testing other than the 2 weeks toxicity labs will be drawn through employee health (or the ER). II. Non-occupational Exposuresa) Sexual Exposures:
b) Needle Exposures:
*** If source is known to be HCV negative, HCV antibody does not need to be drawn during follow-up. *Adobe Acrobat Reader is required for viewing or printing PDFs. Acrobat Reader is available free of charge from the Adobe website at http://www.adobe.com/prodindex/acrobat/readstep.html |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FOR PATIENTS : FOR PROVIDERS : PHARMACY : CALENDAR : RESOURCES About Us : Contact Us : Search : Site Map : Harborview Medical Center : UW Medical Center |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 University of Washington. All rights reserved. Notice of Privacy Practices : Copyright and Disclaimer : Credits and Acknowledgements |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||